Ieq Capital, LLC Eli Lilly & CO Transaction History

Ieq Capital, LLC

$8.04 Billion
Q3 2024

A detailed history of Ieq Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ieq Capital, LLC holds 62,189 shares of LLY stock, worth $49.5 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

62,189

Previous 54,453 14.21%

Holding current value

$49.5 Million

Previous $49.3 Million 11.75%

% of portfolio

0.68%

Previous 0.67%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $5.97 Million - $7.43 Million	7,736 Added 14.21%	62,189 $55.1 Million
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $4.02 Million - $5.05 Million	5,550 Added 11.35%	54,453 $49.3 Million
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $2.29 Million - $3.06 Million	3,866 Added 8.58%	48,903 $38 Million
Q4 2023 Feb 07, 2024	BUY	$525.19 - $619.13 $1.68 Million - $1.98 Million	3,205 Added 7.66%	45,037 $26.3 Million
Q3 2023 Nov 03, 2023	BUY	$434.7 - $599.3 $997,636 - $1.38 Million	2,295 Added 5.8%	41,832 $22.5 Million
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $1.97 Million - $2.63 Million	5,615 Added 16.55%	39,537 $18.5 Million
Q1 2023 May 01, 2023	SELL	$310.63 - $364.82 $886,538 - $1.04 Million	-2,854 Reduced 7.76%	33,922 $11.6 Million
Q4 2022 Feb 03, 2023	BUY	$321.55 - $374.67 $942,141 - $1.1 Million	2,930 Added 8.66%	36,776 $13.5 Million
Q3 2022 Nov 03, 2022	BUY	$296.48 - $337.87 $2.96 Million - $3.37 Million	9,978 Added 41.8%	33,846 $10.9 Million
Q2 2022 Jul 27, 2022	BUY	$278.73 - $327.27 $1.37 Million - $1.61 Million	4,930 Added 26.03%	23,868 $7.74 Million
Q1 2022 Apr 26, 2022	BUY	$234.69 - $291.66 $716,743 - $890,729	3,054 Added 19.23%	18,938 $5.42 Million
Q4 2021 Jan 31, 2022	BUY	$224.85 - $279.04 $308,044 - $382,284	1,370 Added 9.44%	15,884 $4.39 Million
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $195,229 - $240,257	881 Added 6.46%	14,514 $3.35 Million
Q2 2021 Jul 29, 2021	BUY	$180.55 - $233.54 $602,495 - $779,322	3,337 Added 32.41%	13,633 $3.13 Million
Q1 2021 May 04, 2021	BUY	$164.32 - $212.72 $1.69 Million - $2.19 Million	10,296 New	10,296 $1.92 Million
Q4 2020 Feb 03, 2021	SELL	$130.46 - $172.63 $918,568 - $1.22 Million	-7,041 Closed	0 $0
Q3 2020 Nov 03, 2020	SELL	$146.22 - $169.13 $158,210 - $182,998	-1,082 Reduced 13.32%	7,041 $1.04 Million
Q2 2020 Jul 31, 2020	BUY	$136.42 - $164.18 $7,639 - $9,194	56 Added 0.69%	8,123 $1.33 Million
Q1 2020 May 07, 2020	BUY	$119.05 - $147.35 $225,599 - $279,228	1,895 Added 30.7%	8,067 $1.12 Million
Q4 2019 Feb 11, 2020	SELL	$106.92 - $132.43 $226,777 - $280,884	-2,121 Reduced 25.58%	6,172 $811,000
Q4 2019 Feb 04, 2020	BUY	$106.92 - $132.43 $886,687 - $1.1 Million	8,293 New	8,293 $673,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.

Account